A new fund to invest in vaccines for emerging infectious diseases has been established, with $460 million in contributions from the governments of Norway, Japan and Germany, the Wellcome Trust and the Bill and Melinda Gates Foundation.
The Coalition for Epidemic Preparedness Innovations (CEPI) made the announcement at the World Economic Forum in Davos, Switzerland, where it is seeking an additional $500 million from funders.
The group will invest in research to: “...outsmart epidemics by developing vaccines against known infectious disease threats that could be deployed rapidly to contain outbreaks, before they become global health emergencies.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze